Michael J. Jung - Concepedia

Author

Michael J. Jung

Also Known As

M J Jung, M. J. JUNG, M. J. Jung, M. JUNG, M. Jung, M.J. Jung, MICHAEL J. JUNG, Michael J. Jung, Michael Jung, Myeongseok Jung

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Fondation Jean-Marie Lehn New York University University of Michigan University of Delaware California University of Pennsylvania

About

Michael J. Jung is an author at Fondation Jean-Marie Lehn specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	2.1K
2	Business	8	8	807
3	Management	4	4	617
4	Arts	2	2	440
5	Engineering	2	2	63

Michael J. Jung

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs Brian W. Metcalf, Philippe Bey, Charles Danzin, Journal of the American Chemical Society Drug TargetAltmetric Attention ScoreChemical BiologyEnzymatic ModificationPharmaceutical Chemistry	1978	1K
γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE<sup>1</sup> Michael J. Jung, Bruce Lippert, Brian W. Metcalf, Journal of Neurochemistry Molecular Pharmacologyγ‐Vinyl GabaBrain Gaba MetabolismMolecular NeuroscienceBiochemistry	1977	479
Do Firms Strategically Disseminate? Evidence from Corporate Use of Social Media Michael J. Jung, James P. Naughton, Ahmed Tahoun, The Accounting Review Social Medium MonitoringCommunicationJournalismSocial MediaTwitter Dissemination	2017	348
THE EFFECT OF 4‐AMINO HEX‐5‐YNOIC ACID (γ‐ACETYLENIC GABA, γ‐ETHYNYL GABA) A CATALYTIC INHIBITOR OF GABA TRANSAMINASE, ON BRAIN GABA METABOLISM <i>IN VIVO</i> Michael J. Jung, Bruce Lippert, Brian W. Metcalf, Journal of Neurochemistry Neuromodulation TherapiesExperimental PharmacologySocial SciencesGaba ConcentrationMolecular Pharmacology	1977	217
Do Investors Benefit from Selective Access to Management? Brian J. Bushee, Michael J. Jung, Gregory S. Miller Journal of Financial Reporting Market MicrostructureCorporate ManagersMergers And AcquisitionsOwnership StructureMarket Manipulation	2017	147
Buy‐Side Analysts and Earnings Conference Calls Michael J. Jung, M.H. Franco Wong, Frank Zhang Journal of Accounting Research Conference CallsSecurities LawStock PricesManagement QuestionsFinancial Management	2017	99
Enzyme-activated irreversible inhibitors of L-ornithine:2-oxoacid aminotransferase. Demonstration of mechanistic features of the inhibition of ornithine aminotransferase by 4-aminohex-5-ynoic acid and gabaculine and correlation with in vivo activity. Michael J. Jung, Nikolaus Seiler Journal of Biological Chemistry Molecular PharmacologyBiochemistryOrnithine AminotransferaseVivo Ornithine DegradationMedicine	1978	97
Conference Presentations and the Disclosure Milieu Brian J. Bushee, Michael J. Jung, Gregory S. Miller Journal of Accounting Research Conference CharacteristicsOrganizational CommunicationConference PresentationsStrategic CommunicationCommunication Effects	2011	92
Do Investors Benefit from Selective Access to Management? Brian J. Bushee, Michael J. Jung, Gregory S. Miller SSRN Electronic Journal	2011	88
Analogs of ornithine as inhibitors of ornithine decarboxylase. New deductions concerning the topography of the enzyme's active site Philippe Bey, Charles Danzin, V. Van Dorsselaer, Journal of Medicinal Chemistry Pharmaceutical ScienceNew DeductionsPharmacotherapyChemical BiologyEnzymatic Modification	1978	86

Page 1